A detailed history of Cm Management, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Cm Management, LLC holds 150,000 shares of EOLS stock, worth $1.63 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares
150,000
Previous 150,000 -0.0%
Holding current value
$1.63 Million
Previous $1.63 Million 49.35%
% of portfolio
2.04%
Previous 1.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$7.15 - $10.2 $536,250 - $765,000
75,000 Added 100.0%
150,000 $1.37 Million
Q2 2023

Aug 04, 2023

BUY
$7.23 - $10.52 $542,250 - $789,000
75,000 New
75,000 $545,000
Q1 2021

May 12, 2021

SELL
$3.2 - $16.51 $149,184 - $769,696
-46,620 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$2.92 - $4.84 $136,130 - $225,640
46,620 New
46,620 $157,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $611M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Cm Management, LLC Portfolio

Follow Cm Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cm Management, LLC with notifications on news.